The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Dallas Matthew D since 2015.
The trader's CIK number is 1612396.
At the time of the last reporting, Dallas Matthew D was the VP, Finance of Colucid Pharmaceuticals, Inc.. (stock ticker symbol CLCD).
Also see all insider trading activities at Colucid Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | AVEO | 0 | $0 | 3,594 | $2,927 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | CLCD | 0 | $0 | 1,473 | $53,396 | 0 | $0 |
2016 | CLCD | 0 | $0 | 1,473 | $51,800 | 0 | $0 |
1. Aveo Pharmaceuticals, Inc. (AVEO)
2. Colucid Pharmaceuticals, Inc. (CLCD)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-01-16 | AVEO | Sale | 3,075 | .82 | 2,512 |
2015-01-07 | AVEO | Sale | 519 | .80 | 415 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-01-03 | CLCD | Sale | 1,473 | 36.25 | 53,396 |
2016-12-01 | CLCD | Sale | 1,473 | 35.17 | 51,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dallas Matthew D (VP, Finance of Colucid Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.